Sansure Biotech Inc. (SHA:688289)

Sansure Biotech Revenue

Sansure Biotech had revenue of 437.35M CNY in the quarter ending March 31, 2026, a decrease of -8.02%. This brings the company's revenue in the last twelve months to 1.60B, up 3.94% year-over-year. In the year 2025, Sansure Biotech had annual revenue of 1.64B with 12.58% growth.

• Revenue (ttm): 1.60B
• Revenue Growth: +3.94%
• P/S Ratio: 6.49
• Revenue / Employee: 683.46K
• Employees: 2,409
• Market Cap: 10.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.64B	183.47M	12.58%
Dec 31, 2024	1.46B	450.94M	44.78%
Dec 31, 2023	1.01B	-5.44B	-84.39%
Dec 31, 2022	6.45B	1.94B	42.88%
Dec 31, 2021	4.51B	-248.42M	-5.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 6, 2026

Data Sources Report a data error